Analytical Overview: Ardent Health Inc (ARDT)’s Ratios Tell a Financial Story

Ulysses Smith

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

As of close of business last night, Ardent Health Inc’s stock clocked out at $8.59, up 0.12% from its previous closing price of $8.58. In other words, the price has increased by $0.12 from its previous closing price. On the day, 0.61 million shares were traded. ARDT stock price reached its highest trading level at $8.805 during the session, while it also had its lowest trading level at $8.585.

Ratios:

To gain a deeper understanding of ARDT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.94. For the most recent quarter (mrq), Quick Ratio is recorded 1.95 and its Current Ratio is at 2.08. In the meantime, Its Debt-to-Equity ratio is 1.84 whereas as Long-Term Debt/Eq ratio is at 1.82.

On October 14, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $19.Goldman initiated its Neutral rating on October 14, 2025, with a $19 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDT now has a Market Capitalization of 1229982208 and an Enterprise Value of 3321968640. As of this moment, Ardent’s Price-to-Earnings (P/E) ratio for their current fiscal year is 5.95, and their Forward P/E ratio for the next fiscal year is 6.13. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.19 while its Price-to-Book (P/B) ratio in mrq is 0.99. Its current Enterprise Value per Revenue stands at 0.525 whereas that against EBITDA is 6.257.

Stock Price History:

The Beta on a monthly basis for ARDT is 0.74, which has changed by -0.4935065 over the last 52 weeks, in comparison to a change of 0.12529528 over the same period for the S&P500. Over the past 52 weeks, ARDT has reached a high of $17.34, while it has fallen to a 52-week low of $8.28. The 50-Day Moving Average of the stock is -30.72%, while the 200-Day Moving Average is calculated to be -33.74%.

Shares Statistics:

It appears that ARDT traded 529.98K shares on average per day over the past three months and 560470 shares per day over the past ten days. A total of 143.17M shares are outstanding, with a floating share count of 23.22M. Insiders hold about 83.78% of the company’s shares, while institutions hold 14.06% stake in the company. Shares short for ARDT as of 1763078400 were 2753446 with a Short Ratio of 5.20, compared to 1760486400 on 2917742. Therefore, it implies a Short% of Shares Outstanding of 2753446 and a Short% of Float of 8.25.

Earnings Estimates

. The current rating of Ardent Health Inc (ARDT) reflects the combined expertise of 4.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.24, with high estimates of $0.3 and low estimates of $0.18.

Analysts are recommending an EPS of between $1.86 and $1.86 for the fiscal current year, implying an average EPS of $1.86. EPS for the following year is $1.44, with 5.0 analysts recommending between $1.6 and $1.26.

Revenue Estimates

In. The current quarter, 11 analysts expect revenue to total $1.63B. It ranges from a high estimate of $1.68B to a low estimate of $1.6B. As of. The current estimate, Ardent Health Inc’s year-ago sales were $1.61BFor the next quarter, 11 analysts are estimating revenue of $1.59B. There is a high estimate of $1.64B for the next quarter, whereas the lowest estimate is $1.56B.

A total of 12 analysts have provided revenue estimates for ARDT’s current fiscal year. The highest revenue estimate was $6.42B, while the lowest revenue estimate was $6.32B, resulting in an average revenue estimate of $6.36B. In the same quarter a year ago, actual revenue was $5.97BBased on 12 analysts’ estimates, the company’s revenue will be $6.65B in the next fiscal year. The high estimate is $6.9B and the low estimate is $6.47B.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.